CoChat

Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms

Zaongo, Silvere D., Wu, Wenlin, Chen, Yaokai · 2025 · Frontiers in Psychiatry
Cited by 5

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Cumulative evidence indicates that compared to HIV negative individuals, people living with HIV (PLWH) have a higher likelihood of developing depression, anxiety, and cognitive disorders. Depression, which is known to be a persistent and overwhelming feeling of sadness accompanied by a loss of interest in usual activities, is one of the most common mental illnesses encountered during HIV infection. Experts believe that several factors such as neuroinflammation, life stressors, lack of sleep, poor nutritional state, opportunistic infections and comorbidities, and HIV medications are contributing factors favoring the development of depression in PLWH. However, the fundamental mechanisms which underlie the involvement of these factors in the emergence of depression in the context of HIV remain poorly explored. Past researches describing the role of one or two of the preceding factors do exist; however, very few articles tackle this important topic while considering the several different putative causative factors comprehensively in the particular context of HIV infection. Herein, we elaborate on the factors currently understood to be responsible for the development of depression, and discuss the particular fundamental mechanisms whereby each factor may result in the outcome of depression. We believe that the understanding of these factors and of their underlying mechanisms is essential for the development of future therapeutic interventions to alleviate the burden of depression commonly seen in PLWH, and therefore facilitate the development of strategies to improve their overall quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2025.1557816

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 245

  1. Luxton, 2022, Depression in children and young people: identification and management NICE guidelines, Arch Dis Child Educ Pract Ed, 107, 10.1136/archdischild-2020-320020 · DOI
  2. Edinoff, 2021, Selective serotonin reuptake inhibitors and adverse effects: A narrative review, Neurol Int, 13, 387, 10.3390/neurolint13030038 · DOI · Paper page
  3. Gebru, 2024, Prevalence of depression and associated factors among HIV/AIDS patients attending antiretroviral therapy clinic at Adama Hospital Medical College, Adama, Central Ethiopia, Sci Rep, 14, 1642, 10.1038/s41598-024-52142-z · DOI
  4. Xu, 2017, MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology, PLoS Pathog, 13, 10.1371/journal.ppat.1006360 · DOI · Paper page
  5. Muche, 2020, Patient reported central nervous system adverse events of efavirenz-based antiretroviral therapy in people living with HIV in northwest Ethiopia, HIV AIDS (Auckl), 12, 10.2147/hiv.s276111 · doi:10.2147/hiv.s276111
  6. Sekine, 2023, Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study, J Pharm Health Care Sci, 9, 9, 10.1186/s40780-023-00277-y · DOI
  7. Troncoso, 2015, Prevalence of neurocognitive disorders and depression in a Brazilian HIV population, Rev Soc Bras Med Trop, 48, 10.1590/0037-8682-0034-2015 · DOI
  8. Burki, 2022, Guidelines for visceral leishmaniasis and HIV co-infection, Lancet Infect Dis, 22, 10.1016/s1473-3099(22)00461-3 · doi:10.1016/s1473-3099(22)00461-3
  9. Niu, 2016, The mental health of people living with HIV in China, 1998-2014: A systematic review, PLoS One, 11, 10.1371/journal.pone.0153489 · DOI
  10. Niu, 2019, Longitudinal trajectories of emotional problems and unmet mental health needs among people newly diagnosed with HIV in China, J Int AIDS Soc, 22, 10.1002/jia2.25332 · DOI
  11. Jiang, 2019, Prevalence of and factors associated with major depressive disorder among HIV-positive individuals in Guangdong, China, J Affect Disord, 246, 10.1016/j.jad.2018.12.130 · DOI
  12. Lofgren, 2020, Burden of depression in outpatient HIV-infected adults in sub-Saharan Africa; systematic review and meta-analysis, AIDS Behav, 24, 10.1007/s10461-019-02706-2 · DOI
  13. Choi, 2016, Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV treatment network cohort study, PLoS One, 11, 10.1371/journal.pone.0165816 · DOI
  14. Pence, 2018, Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV-infected adults in the United States, JAMA Psychiatry, 75, 10.1001/jamapsychiatry.2017.4726 · DOI · Paper page
  15. Woods, 2023, Under-representation of low and middle income countries (LMIC) in the research literature: Ethical issues arising from a survey of five leading medical journals: have the trends changed, Glob Public Health, 18, 10.1080/17441692.2023.2229890 · DOI
  16. Chibanda, 2017, Depression and HIV: integrated care towards 90-90-90, Int Health, 9, 10.1093/inthealth/ihw058 · DOI
  17. Ngum, 2017, Depression among HIV/AIDS patients on highly active antiretroviral therapy in the southwest regional hospitals of Cameroon: A cross-sectional study, Neurol Ther, 6, 10.1007/s40120-017-0065-9 · DOI
  18. Amare, 2018, Prevalence and associated factors of depression among PLHIV in Ethiopia: systematic review and meta-analysis, 2017, AIDS Res Treat, 2018, 10.1155/2018/5462959 · DOI
  19. Sarno, 2021, Neuroimmunology of depression, Adv Pharmacol, 91, 10.1016/bs.apha.2021.03.004 · DOI
  20. Juruena, 2018, Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review, J Affect Disord, 233, 45, 10.1016/j.jad.2017.09.052 · DOI · Paper page
  21. Bhatt, 2023, Targeting inflammation: a potential approach for the treatment of depression, Metab Brain Dis, 38, 45, 10.1007/s11011-022-01095-1 · DOI
  22. Loula, 2022, Monoamine neurotransmitters and mood swings: a dynamical systems approach, Math Biosci Eng, 19, 10.3934/mbe.2022187 · DOI
  23. Beck, 1996, Manual for the beck depression inventory-II, psychol Corporation, 10.1037/t00742-000 · DOI · Paper page
  24. Osman, 2004, Reliability and validity of the beck depression inventory-II with adoslescent psychiatric inpatients, psychol Assess, 16, 10.1037/1040-3590.16.2.120 · DOI · Paper page
  25. Beck, 1961, An inventory for measuring depression, Arch Gen Psychiatry, 4, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
  26. Radloff, 1977, The CES-D scale:A self-report depression scale for research in the general population, Appl psychol Measurement, 1, 385, 10.1177/014662167700100306 · DOI · Paper page
  27. Saracino, 2020, Confirmatory factor analysis of the center for epidemiologic studies depression scale in oncology with examination of invariance between younger and Older patients, Eur J psychol Assess, 36, 10.1027/1015-5759/a000510 · DOI
  28. 1990, EuroQol - a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
  29. Brooks, 1996, EuroQol: the current state of play, Health Policy, 37, 53, 10.1016/0168-8510(96)00822-6 · DOI · Paper page
  30. Hamilton, 1960, Rating scale for depression, J Neurology Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  31. Montgomery, 2018, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 10.1192/bjp.134.4.382 · DOI · Paper page
  32. D’Zurilla, 1990, Development and preliminary evaluation of the socialproblem-solving inventory, psychol Assess, 2
  33. D’Zurilla, 2002, Social problem-solving inventory-revised (SPSI-R), Multi-Health Syst
  34. Meranda, 1996, BASC: behavior assessment system for children, Measurement Eval Couns Dev, 28
  35. Reynolds, 2015, Behavior assessment system for children (3rd ed.), Pearson Assessments
  36. Achenbach, 1978, The child behavior profile: an empirically based system for assessing children’s behavioral problems and competencies, Int J Ment Health, 7, 24, 10.1080/00207411.1978.11448806 · DOI · Paper page
  37. Kariuki, 2016, Evaluation of psychometric properties and factorial structure of the pre-school child behaviour checklist at the Kenyan Coast, Child Adolesc Psychiatry Ment Health, 10, 10.1186/s13034-015-0089-9 · DOI
  38. Kovacs, 1981, Rating scales to assess depression in school-aged children, Acta Paedopsychiatrica: Int J Child &Adolescent Psychiatry, 46
  39. Sun, 2015, The children’s depression inventory in worldwide child development research: A reliability generalization study, J Child Family Stud, 24, 10.1007/s10826-014-0038-x · DOI
  40. Poznanski, 1979, A depression rating scale for children, Pediatrics, 64, 10.1542/peds.64.4.442 · DOI · Paper page
  41. Mayes, 2010, Psychometric properties of the children’s depression rating scale–revised in adolescents, J Child Adolesc Psychopharmacol, 20, 10.1089/cap.2010.0063 · DOI · Paper page
  42. Neufeld, 2010, Enhanced measurement sensitivity of hopeless ideation among older adults at risk of self-harm: Reliability and validity of Likert-type responses to the Beck Hopelessness Scale, Aging Ment Health, 14, 10.1080/13607860903421052 · DOI · Paper page
  43. Rush, 2003, The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol Psychiatry, 54, 10.1016/S0006-3223(02)01866-8 · DOI · Paper page
  44. Robitaille, 2010, Factorial structure and psychometric properties of the reminiscence functions scale, Aging Ment Health, 14, 10.1080/13607860903167820 · DOI
  45. Webster, 1993, Construction and validation of the reminiscence functions scale, J Gerontology, 48, 10.1093/geronj/48.5.P256 · DOI · Paper page
  46. Ware, 1992, The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection, Med Care, 30, 10.1097/00005650-199206000-00002 · DOI · Paper page
  47. Gameroff, 2012, Testing the short and screener versions of the social adjustment scale – self-report (SAS-SR), Int J Methods Psychiatr Res, 21, 52, 10.1002/mpr.358 · DOI · Paper page
  48. Weissman, 1976, Assessment of social adjustment by patient self-report, Arch Gen Psychiatry, 33, 10.1001/archpsyc.1976.01770090101010 · DOI · Paper page
  49. Tyrer, 2005, The social functioning questionnaire: A rapid and robust measure of perceived functioning, Int J Soc Psychiatry, 51, 10.1177/0020764005057391 · DOI · Paper page
  50. Lopez, 2010, A psychometric study of the geriatric depression scale, Eur J psychol Assess, 26, 55, 10.1027/1015-5759/a000008 · DOI · Paper page
  51. Yesavage, 1982, Development and validation of a geriatric depression screening scale: A preliminary report, J Psychiatr Res, 17, 37, 10.1016/0022-3956(82)90033-4 · DOI · Paper page
  52. Neugarten, 1961, The measurement of life satisfaction*, J Gerontology, 16, 10.1093/geronj/16.2.134 · DOI · Paper page
  53. Adams, 1969, Analysis of a life satisfaction index, J Gerontology, 24, 10.1093/geronj/24.4.470 · DOI · Paper page
  54. Sullivan, 2000, Genetic epidemiology of major depression: review and meta-analysis, Am J Psychiatry, 157, 10.1176/appi.ajp.157.10.1552 · DOI · Paper page
  55. Tansey, 2013, Contribution of common genetic variants to antidepressant response, Biol Psychiatry, 73, 10.1016/j.biopsych.2012.10.030 · DOI · Paper page
  56. Cardenas, 2023, Prevention of the vertical transmission of HIV; A recap of the journey so far, Viruses, 15, 10.3390/v15040849 · DOI
  57. Yao, 2019, The roles of microRNAs in epigenetic regulation, Curr Opin Chem Biol, 51, 10.1016/j.cbpa.2019.01.024 · DOI · Paper page
  58. Bao, 2004, MicroRNA binding sites in Arabidopsis class III HD-ZIP mRNAs are required for methylation of the template chromosome, Dev Cell, 7, 10.1016/j.devcel.2004.10.003 · DOI · Paper page
  59. Rajewsky, 2006, microRNA target predictions in animals, Nat Genet, S8, 10.1038/ng1798 · DOI · Paper page
  60. Juźwik, 2019, microRNA dysregulation in neurodegenerative diseases: A systematic review, Prog Neurobiol, 182, 10.1016/j.pneurobio.2019.101664 · DOI · Paper page
  61. Rashid, 2022, The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives, Front Immunol, 13, 10.3389/fimmu.2022.1091543 · DOI
  62. Eletto, 2008, Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a, J Cell Physiol, 216, 10.1002/jcp.21452 · DOI · Paper page
  63. Mukerjee, 2011, Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders, J Biol Chem, 286, 10.1074/jbc.M111.241547 · DOI
  64. Yelamanchili, 2010, MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease, Cell Death Dis, 1, 10.1038/cddis.2010.56 · DOI · Paper page
  65. Ryan, 2019, Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy, Psychol Med, 49, 10.1017/s0033291718002556 · DOI
  66. Bol, 2012, Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia, PLoS One, 7, 10.1371/journal.pone.0030990 · DOI
  67. Jasinska, 2022, CCR5 as a coreceptor for human immunodeficiency virus and simian immunodeficiency viruses: A prototypic love-hate affair, Front Immunol, 13, 10.3389/fimmu.2022.835994 · DOI
  68. Sundermann, 2015, Genetic predictor of working memory and prefrontal function in women with HIV, J Neurovirol, 21, 81, 10.1007/s13365-014-0305-z · DOI
  69. Timmermans, 2019, A general introduction to glucocorticoid biology, Front Immunol, 10, 10.3389/fimmu.2019.01545 · DOI · Paper page
  70. Matosin, 2023, Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex, Acta Neuropathol, 145, 10.1007/s00401-023-02541-9 · DOI
  71. Podgorny, 2021, Glucocorticoid-mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis, J Neurochem, 157, 10.1111/jnc.15265 · DOI
  72. Zacková, 2021, Cognitive impairment and depression: Meta-analysis of structural magnetic resonance imaging studies, NeuroImage Clin, 32, 10.1016/j.nicl.2021.102830 · DOI · Paper page
  73. Lubitz, 2022, Adrenal function in HIV infection, 10.1007/978-3-030-84367-0_62 · DOI
  74. Villette, 1990, Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus, J Clin Endocrinol Metab, 70, 10.1210/jcem-70-3-572 · DOI · Paper page
  75. Dobs, 1988, Endocrine disorders in men infected with human immunodeficiency virus, Am J Med, 84, 10.1016/0002-9343(88)90144-1 · DOI · Paper page
  76. Nassoro, 2019, Adrenal insufficiency: A forgotten diagnosis in HIV/AIDS patients in developing countries, Int J Endocrinol, 2019, 10.1155/2019/2342857 · DOI
  77. Mathavan, 2022, Management of adrenal insufficiency in the setting of chronic HIV and advanced extra-adrenal Hodgkin lymphoma, BMJ Case Rep, 15, 10.1136/bcr-2022-249269 · DOI
  78. Odeniyi, 2013, Adrenocortical function in Nigerians with human immunodeficiency virus infection, Ghana Med J, 47
  79. Lo, 2010, Adrenal function in HIV infection, Curr Opin Endocrinol Diabetes Obes, 17, 10.1097/MED.0b013e3283394441 · DOI
  80. Akase, 2018, Occurrence of hypocortisolism in HIV patients: Is the picture changing, Ghana Med J, 52, 10.4314/gmj.v52i3.7 · doi:10.4314/gmj.v52i3.7
  81. Ferreiro, 1988, Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS), Pathology, 20, 10.3109/00313028809059495 · doi:10.3109/00313028809059495
  82. Bertorini, 2014, Neurologic complications of disorders of the adrenal glands, Handb Clin Neurol, 120, 10.1016/b978-0-7020-4087-0.00050-4 · DOI
  83. Almeida, 2020, Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic, Clinics (Sao Paulo), 75, 10.6061/clinics/2020/e2022 · DOI
  84. Norbiato, 1992, Cortisol resistance in acquired immunodeficiency syndrome, J Clin Endocrinol Metab, 74, 10.1210/jcem.74.3.1740494 · doi:10.1210/jcem.74.3.1740494 · Paper page
  85. Vagnucci, 1993, Circadian rhythm of lymphocytes and their glucocorticoid receptors in HIV-infected homosexual men, J Acquir Immune Defic Syndr (1988), 6
  86. Benido Silva, 2023, Iatrogenic Cushing’s syndrome: the result of cobicistat and glucocorticoid interaction in an HIV patient after bariatric surgery, Cureus, 15, 10.7759/cureus.34367 · DOI
  87. Fazeli, 2017, Moment-to-moment within-person associations between acts of discrimination and internalized stigma in people living with HIV: An experience sampling study, Stigma Health, 2, 10.1037/sah0000051 · DOI
  88. Garrido-Hernansaiz, 2020, Predictors of anxiety and depression among newly diagnosed people living with HIV: A longitudinal study, Scand J Psychol, 61, 10.1111/sjop.12621 · DOI
  89. Juruena, 2020, The role of early life stress in HPA axis and anxiety, Adv Exp Med Biol, 1191, 10.1007/978-981-32-9705-0_9 · DOI · Paper page
  90. Naughton, 2014, Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease, Handb Clin Neurol, 124, 69, 10.1016/b978-0-444-59602-4.00005-8 · DOI
  91. Song, 2011, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Prog Neuropsychopharmacol Biol Psychiatry, 35, 10.1016/j.pnpbp.2010.06.020 · DOI · Paper page
  92. Liu, 2003, Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level, Exp Neurol, 184, 196, 10.1016/s0014-4886(03)00207-3 · DOI · Paper page
  93. Bolshakov, 2021, Glucocorticoids: Dr. Jekyll and Mr. Hyde of hippocampal neuroinflammation, Biochem (Mosc), 86, 10.1134/s0006297921020048 · DOI
  94. Yang, 2021, Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study, J Psychiatr Res, 135, 10.1016/j.jpsychires.2021.01.018 · DOI
  95. Zádor, 2021, Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression, Int J Mol Sci, 22, 10.3390/ijms22115903 · DOI
  96. Ramírez, 2018, A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis, Biomedica, 38, 10.7705/biomedica.v38i3.3688 · DOI
  97. Carlos, 2017, IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking, J Neuroinflamm, 14, 10.1186/s12974-017-0803-z · DOI · Paper page
  98. Ash, 2021, HIV in the brain: identifying viral reservoirs and addressing the challenges of an HIV cure, Vaccines (Basel), 9, 10.3390/vaccines9080867 · DOI
  99. Rojas-Celis, 2019, New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system, Cells, 8, 10.3390/cells8101245 · DOI
  100. Izquierdo-Useros, 2010, HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse, PloS Pathog, 6, 10.1371/journal.ppat.1000740 · DOI · Paper page
  101. Krishnan, 2008, The molecular neurobiology of depression, Nature, 455, 894, 10.1038/nature07455 · DOI · Paper page
  102. Saloner, 2021, Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV, J Neurovirol, 27, 10.1007/s13365-020-00925-1 · DOI
  103. Uint, 2019, Increased levels of plasma IL-1b and BDNF can predict resistant depression patients, Rev Assoc Med Bras (1992), 65, 10.1590/1806-9282.65.3.361 · DOI
  104. Salvo-Romero, 2020, Microbiota-immune interactions: from gut to brain, LymphoSign J, 7, 10.14785/lymphosign-2019-0018 · DOI
  105. Mussano, 2016, Cytokine, chemokine, and growth factor profile of platelet-rich plasma, Platelets, 27, 10.3109/09537104.2016.1143922 · DOI · Paper page
  106. Williams, 2024, The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue, Rev Med Virol, 34, e2519, 10.1002/rmv.2519 · DOI
  107. Feria, 2018, HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood, PLoS One, 13, 10.1371/journal.pone.0192845 · DOI
  108. Nabatanzi, 2023, Increased levels of caspase-1 and IL-1β Among adults with persistent immune activation after 12 years of suppressive antiretroviral therapy in the infectious diseases institute HIV treatment cohort, Open Forum Infect Dis, 10, 10.1093/ofid/ofad539 · DOI
  109. Ting, 2020, Role of interleukin-6 in depressive disorder, Int J Mol Sci, 21, 10.3390/ijms21062194 · DOI · Paper page
  110. Koutsouraki, 2011, Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis, J Neuropsychiatry Clin Neurosci, 23, 10.1176/jnp.23.4.jnp442 · DOI
  111. Jehn, 2010, Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer, Integr Cancer Ther, 9, 10.1177/1534735410370036 · DOI · Paper page
  112. Darcy, 2020, The link between stress and IL-6 is heating up, Cell Metab, 32, 10.1016/j.cmet.2020.07.011 · DOI
  113. Gotohda, 2008, Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis, Hepatogastroenterology, 55
  114. Armah, 2012, HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation, Clin Infect Dis, 55, 10.1093/cid/cis406 · DOI · Paper page
  115. Kalliolias, 2016, TNF biology, pathogenic mechanisms and emerging therapeutic strategies, Nat Rev Rheumatol, 12, 49, 10.1038/nrrheum.2015.169 · DOI · Paper page
  116. van Loo, 2023, Death by TNF: a road to inflammation, Nat Rev Immunol, 23, 289, 10.1038/s41577-022-00792-3 · DOI · Paper page
  117. Probert L., 2015, and its receptors in the CNS: The essential, the desirable and the deleterious effects, Neuroscience, 302, 2, 10.1016/j.neuroscience.2015.06.038 · DOI · Paper page
  118. Ma, 2016, Pathogenetic and therapeutic applications of tumor necrosis factor-α (TNF-α) in major depressive disorder: A systematic review, Int J Mol Sci, 17, 10.3390/ijms17050733 · DOI · Paper page
  119. Ownby, 2009, Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users, J Neuroimmune Pharmacol, 4, 10.1007/s11481-009-9150-x · DOI
  120. Okay, 2020, The effect of antiretroviral therapy on IL-6, IL-1β, TNF-α, IFN-γ Levels and their relationship with HIV-RNA and CD4+ T cells in HIV patients, Curr HIV Res, 18, 10.2174/1570162x18666200712174642 · DOI
  121. Derry, 2022, Links between inflammation, mood, and physical function among older adults with HIV, J Gerontol B Psychol Sci Soc Sci, 77, 50, 10.1093/geronb/gbab027 · DOI
  122. Derry-Vick, 2022, Pain is associated with depressive symptoms, inflammation, and poorer physical function in older adults with HIV, Psychosom Med, 84, 10.1097/psy.0000000000001119 · DOI
  123. Memiah, 2021, Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania, BMC Public Health, 21, 1113, 10.1186/s12889-021-11064-5 · DOI
  124. Rivera-Rivera, 2014, Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy, J Clin Cell Immunol, 5, 10.4172/2155-9899.1000276 · DOI
  125. Milenkovic, 2019, The role of chemokines in the pathophysiology of major depressive disorder, Int J Mol Sci, 20, 10.3390/ijms20092283 · DOI · Paper page
  126. Romero-Sanchiz, 2020, Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy, Sci Rep, 10, 1078, 10.1038/s41598-020-57967-y · DOI
  127. Lin, 2017, Plasma cytokines and chemokines in Zambian children with measles: innate responses and association with HIV-1 coinfection and in-hospital mortality, J Infect Dis, 215, 10.1093/infdis/jix012 · DOI
  128. Mamik, 2016, CXCL8 as a potential therapeutic target for HIV-associated neurocognitive disorders, Curr Drug Targets, 17, 10.2174/1389450116666150626124544 · doi:10.2174/1389450116666150626124544
  129. Lehmann, 2019, Nef-induced CCL2 expression contributes to HIV/SIV brain invasion and neuronal dysfunction, Front Immunol, 10, 10.3389/fimmu.2019.02447 · DOI
  130. Schaller, 2017, Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3, Expert Rev Clin Immunol, 13, 10.1080/1744666x.2017.1384313 · DOI · Paper page
  131. Flórez-Álvarez, 2018, NK cells in HIV-1 infection: from basic science to vaccine strategies, Front Immunol, 9, 10.3389/fimmu.2018.02290 · DOI
  132. Rubin, 2020, Remitted depression and cognition in HIV: The role of cortisol and inflammation, Psychoneuroendocrinology, 114, 10.1016/j.psyneuen.2020.104609 · DOI
  133. Lu, 2019, Inflammation and risk of depression in HIV: prospective findings from the multicenter AIDS cohort study, Am J Epidemiol, 188, 1994, 10.1093/aje/kwz190 · DOI
  134. Mudra Rakshasa-Loots, 2023, Depression and HIV: a scoping review in search of neuroimmune biomarkers, Brain Commun, 5, 10.1093/braincomms/fcad231 · DOI · Paper page
  135. Nutt, 2008, Relationship of neurotransmitters to the symptoms of major depressive disorder, J Clin Psychiatry, 4
  136. Perez-Caballero, 2019, Monoaminergic system and depression, Cell Tissue Res, 377, 10.1007/s00441-018-2978-8 · DOI · Paper page
  137. Dailly, 2004, Dopamine, depression and antidepressants, Fundam Clin Pharmacol, 18, 10.1111/j.1472-8206.2004.00287.x · DOI · Paper page
  138. Zhang, 2017, Depression and anxiety behaviour in a rat model of chronic migraine, J Headache Pain, 18, 27, 10.1186/s10194-017-0736-z · DOI
  139. Mällo, 2007, Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine, Behav Brain Res, 177, 10.1016/j.bbr.2006.11.022 · DOI
  140. Martin-Soelch, 2009, Is depression associated with dysfunction of the central reward system, Biochem Soc Trans, 37, 10.1042/bst0370313 · DOI · Paper page
  141. Tamura, 2022, Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging, Transl Psychiatry, 12, 309, 10.1038/s41398-022-02080-z · DOI
  142. Monick, 2022, Characterization of basal ganglia volume changes in the context of HIV and polysubstance use, Sci Rep, 12, 4357, 10.1038/s41598-022-08364-0 · DOI
  143. Saloner, 2020, Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease, Brain Behav Immun, 90, 10.1016/j.bbi.2020.09.012 · DOI
  144. Goulding, 2019, Age-related decrease in tyrosine hydroxylase immunoreactivity in the substantia nigra and region-specific changes in microglia morphology in HIV-1 Tg rats, Neurotox Res, 36, 10.1007/s12640-019-00077-z · DOI
  145. Kumar, 2009, Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains, J Neurovirol, 15, 10.1080/13550280902973952 · DOI
  146. Ko, 2019, Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy, J Neuroimmune Pharmacol, 14, 10.1007/s11481-018-9809-2 · DOI · Paper page
  147. Miller, 2018, HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific, Glia, 66, 10.1002/glia.23447 · DOI
  148. Mishra, 2018, Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status, Mol Immunol, 96, 10.1016/j.molimm.2018.02.011 · doi:10.1016/j.molimm.2018.02.011
  149. Roscoe, 2014, HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens, J Neuroimmune Pharmacol, 9, 10.1007/s11481-014-9555-z · DOI
  150. Bakshi, 2024, Biochemistry, serotonin
  151. De Deurwaerdère, 2020, Serotonin in health and disease, Int J Mol Sci, 21, 10.3390/ijms21103500 · doi:10.3390/ijms21103500
  152. Bamalan, 2024, Physiology, serotonin
  153. Aleksovski, 2018, SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms, Thromb Res, 165, 24, 10.1016/j.thromres.2018.03.006 · DOI
  154. Park, 2018, Antidepressant-like effects of Gyejibokryeong-Hwan in a mouse model of reserpine-induced depression, BioMed Res Int, 2018, 10.1155/2018/5845491 · DOI
  155. Liu, 2018, Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders, Front Psychol, 9, 10.3389/fpsyg.2018.02201 · DOI · Paper page
  156. Zięba, 2021, Overcoming depression with 5-HT(2A) receptor ligands, Int J Mol Sci, 23, 10.3390/ijms23010010 · DOI
  157. Wang, 2021, Abnormal tryptophan metabolism in HIV and mycobacterium tuberculosis infection, Front Microbiol, 12, 10.3389/fmicb.2021.666227 · DOI
  158. Le Floc’h, 2011, Tryptophan metabolism, from nutrition to potential therapeutic applications, Amino Acids, 41, 10.1007/s00726-010-0752-7 · DOI · Paper page
  159. Friedman, 2018, Analysis, nutrition, and health benefits of tryptophan, Int J Tryptophan Res, 11, 10.1177/1178646918802282 · DOI · Paper page
  160. Baumgartner, 2019, The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis, Cytokine, 122, 154148, 10.1016/j.cyto.2017.09.004 · DOI · Paper page
  161. Murray, 2003, Tryptophan depletion and HIV infection: a metabolic link to pathogenesis, Lancet Infect Dis, 3, 10.1016/s1473-3099(03)00773-4 · DOI
  162. Ferrell, 2014, The impact of HIV-1 on neurogenesis: implications for HAND, Cell Mol Life Sci, 71, 10.1007/s00018-014-1702-4 · DOI
  163. Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol, 4, 10.1038/s41564-018-0337-x · DOI · Paper page
  164. Geng, 2020, Regulation of gut microbiota on immune reconstitution in patients with acquired immunodeficiency syndrome, Front Microbiol, 11, 10.3389/fmicb.2020.594820 · DOI
  165. van Marle, 2013, Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals, PLoS One, 8, 10.1371/journal.pone.0075967 · DOI
  166. Shah, 2019, Potential mechanism for HIV-associated depression: upregulation of serotonin transporters in SIV-infected macaques detected by 11C-DASB PET, Front Psychiatry, 10, 10.3389/fpsyt.2019.00362 · DOI
  167. Hussain, 2024, Physiology, noradrenergic synapse
  168. Fiore, 2023, Norepinephrine regulates calcium signals and fate of oligodendrocyte precursor cells in the mouse cerebral cortex, Nat Commun, 14, 8122, 10.1038/s41467-023-43920-w · DOI
  169. Maletic, 2017, The role of norepinephrine and its α-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: A systematic review, Front Psychiatry, 8, 10.3389/fpsyt.2017.00042 · DOI · Paper page
  170. Khurana, 2019, Lacidipine attenuates reserpine-induced depression-like behavior and oxido-nitrosative stress in mice, Naunyn Schmiedebergs Arch Pharmacol, 392, 10.1007/s00210-019-01667-6 · DOI
  171. Sattar, 2018, A review of the mechanism of antagonism of N-methyl-D-aspartate receptor by ketamine in treatment-resistant depression, Cureus, 10, 10.7759/cureus.2652 · DOI
  172. Fayez, 2024, Imipramine
  173. Ironson, 2015, Psychosocial and neurohormonal predictors of HIV disease progression (CD4 cells and viral load): A 4 year prospective study, AIDS Behav, 19, 10.1007/s10461-014-0877-x · DOI
  174. Saloner, 2020, Cerebrospinal fluid norepinephrine and neurocognition in HIV and methamphetamine dependence, J Acquir Immune Defic Syndr, 85, 10.1097/qai.0000000000002422 · DOI
  175. Potter, 2013, Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders, J Neuroimmune Pharmacol, 8, 594, 10.1007/s11481-013-9442-z · DOI · Paper page
  176. Marino, 2020, Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND, Cell Mol Life Sci, 77, 10.1007/s00018-020-03561-4 · DOI
  177. Vázquez-Santiago, 2014, Glutamate metabolism and HIV-associated neurocognitive disorders, J Neurovirol, 20, 10.1007/s13365-014-0258-2 · DOI
  178. Mudra Rakshasa-Loots, 2022, Neuroinflammation in HIV-associated depression: evidence and future perspectives, Mol Psychiatry, 27, 10.1038/s41380-022-01619-2 · DOI
  179. Michael, 2020, The role of brain derived neurotrophic factor in HIV-associated neurocognitive disorder: from the bench-top to the bedside, Neuropsychiatr Dis Treat, 16, 10.2147/ndt.s232836 · DOI
  180. Hu, 2024, HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis, Front Microbiol, 15, 10.3389/fmicb.2024.1428239 · DOI
  181. Winias, 2020, Neuropathy complication of antiretroviral therapy in HIV/AIDS patients, Oral Dis, 10.1111/odi.13398 · DOI
  182. Drury, 2018, HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz, Malawi Med J, 30, 10.4314/mmj.v30i1.9 · DOI
  183. Xia, 2021, Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV, Chin Med J (Engl), 134, 10.1097/cm9.0000000000001824 · doi:10.1097/cm9.0000000000001824
  184. Zareifopoulos, 2020, Neuropsychiatric effects of antiviral drugs, Cureus, 12, 10.7759/cureus.9536 · DOI
  185. Costa, 2022, Efavirenz: history, development and future, Biomolecules, 13, 10.3390/biom13010088 · DOI
  186. Apostolova, 2015, Efavirenz and the CNS: what we already know and questions that need to be answered, J Antimicrob Chemother, 70, 10.1093/jac/dkv183 · DOI · Paper page
  187. Cocohoba, 2008, Raltegravir: the first HIV integrase inhibitor, Clin Ther, 30, 10.1016/j.clinthera.2008.10.012 · DOI
  188. Fantauzzi, 2014, Dolutegravir: clinical efficacy and role in HIV therapy, Ther Adv Chronic Dis, 5, 10.1177/2040622314530461 · DOI
  189. Cid-Silva, 2017, Clinical experience with the integrase inhibitors dolutegravir and elvitegravir in HIV-infected patients: efficacy, safety and tolerance, Basic Clin Pharmacol Toxicol, 121, 10.1111/bcpt.12828 · doi:10.1111/bcpt.12828
  190. Hoffmann, 2017, Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients, HIV Med, 18, 56, 10.1111/hiv.12468 · DOI
  191. Hoffmann, 2019, Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors, AIDS Rev, 21, 4, 10.24875/AIDSRev.19000023 · DOI
  192. Stern, 2018, Differential effects of antiretroviral drugs on neurons in vitro: roles for oxidative stress and integrated stress response, J Neuroimmune Pharmacol, 13, 64, 10.1007/s11481-017-9761-6 · DOI
  193. Nooka, 2018, Organellar stress intersects the astrocyte endoplasmic reticulum, mitochondria and nucleolus in HIV associated neurodegeneration, Cell Death Dis, 9, 317, 10.1038/s41419-018-0341-3 · DOI
  194. Ekins, 2017, α7-Nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease, Aids, 31, 10.1097/qad.0000000000001488 · DOI
  195. Wu, 2017, Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling, Sci Rep, 7, 4117, 10.1038/s41598-017-03446-w · DOI
  196. Yu, 2018, Combining new non-nucleoside reverse transcriptase inhibitors (RTIs) with AZT results in strong synergism against multi-RTI-resistant HIV-1 strains, Molecules, 23, 10.3390/molecules23071599 · doi:10.3390/molecules23071599
  197. Yang, 2018, Quercetin attenuates AZT-induced neuroinflammation in the CNS, Sci Rep, 8, 6194, 10.1038/s41598-018-24618-2 · DOI
  198. Sörstedt, 2018, Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations, Int J Antimicrob Agents, 51, 10.1016/j.ijantimicag.2018.01.009 · DOI
  199. Ciavatta, 2017, In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals, Neurochem Res, 42, 10.1007/s11064-017-2358-x · DOI
  200. Bienstock, 2004, Molecular insights into NRTI inhibition and mitochondrial toxicity revealed from a structural model of the human mitochondrial DNA polymerase, Mitochondrion, 4, 10.1016/j.mito.2004.05.018 · DOI

200 of 245 shown

Metadata

Authors
Zaongo, S. D., Wu, W., & Chen, Y.
Venue
Frontiers in Psychiatry
Published
2025-04-17
Volume
16
ISSN
1664-0640
Cited by
5
References
34

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.